Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR AlzChem Group AG (ACT.BE) Follow Compare 99.40 -8.60 (-7.96%) At close: 7:50:02 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Vertex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ACT.BE 1D 5D 9.47% 1M 44.90% 3M 72.57% 6M 143.03% YTD 75.62% 1Y 209.66% 5Y 513.58% All 283.19% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: ACT.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Investors Shouldn't Overlook AlzChem Group's (ETR:ACT) Impressive Returns On Capital AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80 AlzChem Group's (ETR:ACT) investors will be pleased with their splendid 282% return over the last five years If EPS Growth Is Important To You, AlzChem Group (ETR:ACT) Presents An Opportunity Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)? AlzChem Group AG (ETR:ACT) has caught the attention of institutional investors who hold a sizeable 45% stake AlzChem Group Third Quarter 2024 Earnings: EPS: €1.22 (vs €0.85 in 3Q 2023) Is AlzChem Group AG's (ETR:ACT) Latest Stock Performance A Reflection Of Its Financial Health? The Return Trends At AlzChem Group (ETR:ACT) Look Promising Estimating The Fair Value Of AlzChem Group AG (ETR:ACT) AlzChem Group (ETR:ACT) shareholders have earned a 25% CAGR over the last five years Related Tickers JMT2.MU Johnson Matthey PLC 17.01 +2.29% DNMR Danimer Scientific, Inc. 0.3500 -69.03% SHW The Sherwin-Williams Company 335.53 -1.96% APD Air Products and Chemicals, Inc. 291.82 -1.29%